Papers

1

Total Citations

163

H-Index

1

About

Dr. Difei Chen is a leading thoracic surgeon whose research focuses on advancing minimally invasive surgical techniques for lung cancer treatment. His most impactful work, a 2017 study comparing robotic-assisted lobectomy/segmentectomy (RAL/S) with video-assisted lobectomy/segmentectomy (VAL/S), has garnered 163 citations and remains a cornerstone in the debate over optimal surgical approaches. This meta-analysis, which systematically evaluated safety and efficacy outcomes, provided crucial evidence that RAL/S is a viable and safe alternative to traditional video-assisted methods, helping to clarify uncertainties in the field. Beyond this landmark paper, Dr. Chen’s broader contributions have shaped clinical guidelines and informed surgical decision-making for radical lung cancer resection. His research demonstrates a commitment to rigorous comparative effectiveness studies, directly impacting patient care by offering surgeons and patients clearer insights into the benefits and risks of emerging technologies. With a citation record that underscores his influence, Dr. Chen continues to be a pivotal voice in thoracic oncology, driving innovation in surgical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
163
Total Citations
163
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Cancer
163 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: First Affiliated Hospital of Guangzhou Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago